SXI Life Sciences
7.772,36
PKT
-3,32
PKT
-0,04
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Leider sind zu diesem Wert keine aktuellen Kursdaten verfügbar, die Stammdaten finden Sie im unteren Seitenbereich.
Analysen zu SXI Life Sciences-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 15.02.21 | Roche Neutral | JP Morgan Chase & Co. | |
| 15.02.21 | Roche Hold | Deutsche Bank AG | |
| 12.02.21 | Roche Outperform | Bernstein Research | |
| 11.02.21 | Roche Conviction Buy | Goldman Sachs Group Inc. | |
| 10.02.21 | Novartis buy | Deutsche Bank AG | |
| 10.02.21 | Roche Neutral | JP Morgan Chase & Co. | |
| 09.02.21 | Novartis buy | Deutsche Bank AG | |
| 05.02.21 | Roche Hold | Deutsche Bank AG | |
| 05.02.21 | Roche Neutral | Credit Suisse Group | |
| 04.02.21 | Roche Outperform | Bernstein Research | |
| 04.02.21 | Roche buy | Jefferies & Company Inc. | |
| 04.02.21 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 03.02.21 | Novartis buy | UBS AG | |
| 03.02.21 | Novartis Underweight | JP Morgan Chase & Co. | |
| 28.01.21 | Roche Neutral | JP Morgan Chase & Co. | |
| 27.01.21 | Novartis Neutral | Credit Suisse Group | |
| 26.01.21 | Roche buy | Goldman Sachs Group Inc. | |
| 26.01.21 | Novartis buy | UBS AG | |
| 26.01.21 | Novartis overweight | Morgan Stanley | |
| 26.01.21 | Novartis Hold | Kepler Cheuvreux | |
| 26.01.21 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 26.01.21 | Novartis buy | Jefferies & Company Inc. | |
| 25.01.21 | Roche Reduce | Oddo BHF | |
| 25.01.21 | Novartis Neutral | Oddo BHF | |
| 25.01.21 | Roche Neutral | JP Morgan Chase & Co. | |
| 22.01.21 | Roche overweight | Barclays Capital | |
| 22.01.21 | Novartis Underweight | Barclays Capital | |
| 21.01.21 | Novartis Conviction Buy | Goldman Sachs Group Inc. | |
| 20.01.21 | Novartis Neutral | Credit Suisse Group | |
| 20.01.21 | Roche Neutral | Credit Suisse Group | |
| 20.01.21 | Novartis buy | Jefferies & Company Inc. | |
| 20.01.21 | Roche buy | Jefferies & Company Inc. | |
| 19.01.21 | Novartis Underweight | JP Morgan Chase & Co. | |
| 15.01.21 | Roche Hold | Deutsche Bank AG | |
| 15.01.21 | Novartis buy | Deutsche Bank AG | |
| 14.01.21 | Novartis buy | UBS AG | |
| 13.01.21 | Novartis Underweight | JP Morgan Chase & Co. | |
| 13.01.21 | Roche Neutral | JP Morgan Chase & Co. | |
| 12.01.21 | Roche buy | UBS AG | |
| 08.01.21 | Novartis overweight | Morgan Stanley |